Belinda E. Kiely

3.2k total citations
81 papers, 1.0k citations indexed

About

Belinda E. Kiely is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Belinda E. Kiely has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Belinda E. Kiely's work include Palliative Care and End-of-Life Issues (18 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Cancer Treatment Studies (17 papers). Belinda E. Kiely is often cited by papers focused on Palliative Care and End-of-Life Issues (18 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Cancer Treatment Studies (17 papers). Belinda E. Kiely collaborates with scholars based in Australia, United States and United Kingdom. Belinda E. Kiely's co-authors include Martin R. Stockler, Martin H.N. Tattersall, Yu Yang Soon, Philip Beale, Prunella Blinman, Andrew Martin, Haryana M. Dhillon, Sallie‐Anne Pearson, Nehmat Houssami and Benjamin Daniels and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Belinda E. Kiely

74 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belinda E. Kiely Australia 19 538 320 228 169 152 81 1.0k
Yanin Chávarri-Guerra Mexico 19 672 1.2× 278 0.9× 194 0.9× 83 0.5× 272 1.8× 81 1.3k
Inge R. Konings Netherlands 17 453 0.8× 228 0.7× 220 1.0× 58 0.3× 126 0.8× 42 1.0k
Ute‐Susann Albert Germany 20 689 1.3× 163 0.5× 171 0.8× 179 1.1× 381 2.5× 55 1.5k
C. Langridge United Kingdom 18 535 1.0× 437 1.4× 128 0.6× 392 2.3× 406 2.7× 29 1.5k
Heather Mackey United States 6 966 1.8× 200 0.6× 345 1.5× 91 0.5× 237 1.6× 9 1.3k
Jacqueline Kerr Germany 13 1.1k 2.1× 186 0.6× 239 1.0× 191 1.1× 300 2.0× 21 1.6k
Tina Hsu Canada 16 492 0.9× 316 1.0× 258 1.1× 101 0.6× 58 0.4× 60 1.1k
Rebecca Cowens-Alvarado United States 8 1.5k 2.8× 347 1.1× 550 2.4× 141 0.8× 277 1.8× 10 2.0k
Ishwaria M. Subbiah United States 19 583 1.1× 175 0.5× 324 1.4× 58 0.3× 140 0.9× 94 1.1k
Johan Ahlgren Sweden 23 1.0k 1.9× 281 0.9× 253 1.1× 148 0.9× 461 3.0× 68 1.7k

Countries citing papers authored by Belinda E. Kiely

Since Specialization
Citations

This map shows the geographic impact of Belinda E. Kiely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belinda E. Kiely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belinda E. Kiely more than expected).

Fields of papers citing papers by Belinda E. Kiely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belinda E. Kiely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belinda E. Kiely. The network helps show where Belinda E. Kiely may publish in the future.

Co-authorship network of co-authors of Belinda E. Kiely

This figure shows the co-authorship network connecting the top 25 collaborators of Belinda E. Kiely. A scholar is included among the top collaborators of Belinda E. Kiely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belinda E. Kiely. Belinda E. Kiely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pearson, A. Scott, Haryana M. Dhillon, Rachel Campbell, et al.. (2025). Genitourinary symptoms in women with breast cancer: frequency, severity and impact. Supportive Care in Cancer. 33(4). 258–258.
3.
Lord, Sarah J., Belinda E. Kiely, Dianne L. O’Connell, et al.. (2023). Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time – An Australian population-based record linkage study, 2001–2016. European Journal of Cancer. 197. 113468–113468. 3 indexed citations
4.
Lord, Sarah J., Benjamin Daniels, Dianne L. O’Connell, et al.. (2023). Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016. Cancer Epidemiology Biomarkers & Prevention. 33(2). 314–324.
5.
Dhillon, Haryana M., et al.. (2023). Scanxiety Conversations on Twitter: Observational Study. JMIR Cancer. 9. e43609–e43609. 2 indexed citations
6.
Martin, Andrew, Josephine M. Clayton, Peter Grimison, et al.. (2023). Accuracy of oncologists’ estimates of expected survival time in advanced cancer. JNCI Cancer Spectrum. 7(6). 1 indexed citations
7.
Lord, Sarah J., Benjamin Daniels, Belinda E. Kiely, et al.. (2022). Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study. The Medical Journal of Australia. 217(8). 402–409. 8 indexed citations
8.
Daniels, Benjamin, Belinda E. Kiely, Mónica Tang, et al.. (2021). Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort. The Breast. 58. 106–112. 8 indexed citations
9.
Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2021). Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study. Breast Cancer Research and Treatment. 187(3). 893–902. 6 indexed citations
10.
Liang, Roger J., et al.. (2021). Scanxiety: a scoping review about scan-associated anxiety. BMJ Open. 11(5). e043215–e043215. 49 indexed citations
11.
Goel, Shom, Jia Liu, Hao Guo, et al.. (2019). Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. JACC Heart Failure. 7(9). 795–804. 30 indexed citations
12.
Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2019). Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 121(11). 904–911. 12 indexed citations
13.
Moylan, Eugene, et al.. (2019). Survival and cardiac toxicity in patients with HER2‐positive, metastatic breast cancer treated with trastuzumab in routine clinical practice. Asia-Pacific Journal of Clinical Oncology. 16(1). 34–38. 2 indexed citations
14.
Daniels, Benjamin, Belinda E. Kiely, Mónica Tang, Hanna Tervonen, & Sallie‐Anne Pearson. (2019). Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015). BMC Cancer. 19(1). 909–909. 5 indexed citations
15.
Wilson, Brooke E., et al.. (2019). Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer. Internal Medicine Journal. 49(11). 1438–1442. 11 indexed citations
16.
Lord, Sarah J., Belinda E. Kiely, Sallie‐Anne Pearson, et al.. (2019). Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol. BMJ Open. 9(2). e026414–e026414. 17 indexed citations
17.
Daniels, Benjamin, Sarah J. Lord, Belinda E. Kiely, et al.. (2017). Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort. BMJ Open. 7(1). e014439–e014439. 16 indexed citations
18.
19.
Tognela, Annette, Jane Beith, Belinda E. Kiely, et al.. (2015). Small HER2-Positive Breast Cancer: Should Size Affect Adjuvant Treatment?. Clinical Breast Cancer. 15(4). 277–284. 6 indexed citations
20.
Kiely, Belinda E., Yu Yang Soon, Martin H.N. Tattersall, & Martin R. Stockler. (2010). How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials. Journal of Clinical Oncology. 29(4). 456–463. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanin Chávarri-Guerra Breakdown of academic impact, for papers by Inge R. Konings Breakdown of academic impact, for papers by Ute‐Susann Albert Breakdown of academic impact, for papers by C. Langridge Breakdown of academic impact, for papers by Heather Mackey Breakdown of academic impact, for papers by Jacqueline Kerr Breakdown of academic impact, for papers by Tina Hsu Breakdown of academic impact, for papers by Rebecca Cowens-Alvarado Breakdown of academic impact, for papers by Ishwaria M. Subbiah Breakdown of academic impact, for papers by Johan Ahlgren
Rankless by CCL
2026